Is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes ? Secondary analyses from a randomized controlled trial

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

Is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes ? Secondary analyses from a randomized controlled trial. / Van Bastelaar, K.M.P.; Pouwer, F.; Cuijpers, P. et al.

in: Journal of Medical Internet Research, Jahrgang 14, Nr. 1, e2, 05.01.2012.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

APA

Vancouver

Bibtex

@article{3cb3dbf1fa3f4a1fb93c5a300d0cff9b,
title = "Is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes ?: Secondary analyses from a randomized controlled trial",
abstract = "Background: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. Objective: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). Methods: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008-2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. Results: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. Conclusions: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile.",
keywords = "Health sciences, Adults, Behavior therapy, Cognitive therapy, Depression, Depressive disorder, Diabetes mellitus type 1, Diabetes mellitus type 2, Psychology, Psychology",
author = "{Van Bastelaar}, K.M.P. and F. Pouwer and P. Cuijpers and H. Riper and J.W.R. Twisk and F.J. Snoek",
note = "Copyright 2012 Elsevier B.V., All rights reserved.",
year = "2012",
month = jan,
day = "5",
doi = "10.2196/jmir.1657",
language = "English",
volume = "14",
journal = "Journal of Medical Internet Research",
issn = "1439-4456",
publisher = "JMIR Publications",
number = "1",

}

RIS

TY - JOUR

T1 - Is a severe clinical profile an effect modifier in a web-based depression treatment for adults with type 1 or type 2 diabetes ?

T2 - Secondary analyses from a randomized controlled trial

AU - Van Bastelaar, K.M.P.

AU - Pouwer, F.

AU - Cuijpers, P.

AU - Riper, H.

AU - Twisk, J.W.R.

AU - Snoek, F.J.

N1 - Copyright 2012 Elsevier B.V., All rights reserved.

PY - 2012/1/5

Y1 - 2012/1/5

N2 - Background: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. Objective: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). Methods: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008-2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. Results: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. Conclusions: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile.

AB - Background: Depression and diabetes are two highly prevalent and co-occurring health problems. Web-based, diabetes-specific cognitive behavioral therapy (CBT) depression treatment is effective in diabetes patients, and has the potential to be cost effective and to have large reach. A remaining question is whether the effectiveness differs between patients with seriously impaired mental health and patients with less severe mental health problems. Objective: To test whether the effectiveness of an eight-lesson Web-based, diabetes-specific CBT for depression, with minimal therapist support, differs in patients with or without diagnosed major depressive disorder (MDD), diagnosed anxiety disorder, or elevated diabetes-specific emotional distress (DM-distress). Methods: We used data of 255 patients with diabetes with elevated depression scores, who were recruited via an open access website for participation in a randomized controlled trial, conducted in 2008-2009, comparing a diabetes-specific, Web-based, therapist-supported CBT with a 12-week waiting-list control group. We performed secondary analyses on these data to study whether MDD or anxiety disorder (measured using a telephone-administered diagnostic interview) and elevated DM-distress (online self-reported) are effect modifiers in the treatment of depressive symptoms (online self-reported) with Web-based diabetes-specific CBT. Results: MDD, anxiety disorder, and elevated DM-distress were not significant effect modifiers in the treatment of self-assessed depressive symptoms with Web-based diabetes-specific CBT. Conclusions: This Web-based diabetes-specific CBT depression treatment is suitable for use in patients with severe mental health problems and those with a less severe clinical profile.

KW - Health sciences

KW - Adults

KW - Behavior therapy

KW - Cognitive therapy

KW - Depression

KW - Depressive disorder

KW - Diabetes mellitus type 1

KW - Diabetes mellitus type 2

KW - Psychology

KW - Psychology

UR - http://www.scopus.com/inward/record.url?scp=84856238978&partnerID=8YFLogxK

U2 - 10.2196/jmir.1657

DO - 10.2196/jmir.1657

M3 - Journal articles

C2 - 22262728

AN - SCOPUS:84856238978

VL - 14

JO - Journal of Medical Internet Research

JF - Journal of Medical Internet Research

SN - 1439-4456

IS - 1

M1 - e2

ER -

Dokumente

DOI